ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Rhode Island » Internal Medicine

Top Internal Medicine Prescribers in Rhode Island

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DANA CHOFAY MD

Internal Medicine

1,085

$61.7K

100
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $51

DAVID FRIED MD

Internal Medicine

10,740

$610K

408
369 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $51

FREDERICK CRISAFULLI MD

Internal Medicine

12,149

$689K

722
633 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $51

STEVEN BRIN MD

Internal Medicine

8,544

$483K

418
361 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

WILLIAM MASON M.D.

Internal Medicine

6,028

$340K

344
252 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 7%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

OLGA TVERSKAYA M.D.

Internal Medicine

14,018

$789K

457
364 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

GREIGSTONE YEARWOOD M.D.

Internal Medicine

13,567

$762K

488
369 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

NICHOLAS TURILLI D.O.

Internal Medicine

16,104

$905K

631
572 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

ALBERTO SAVORETTI M.D.

Internal Medicine

2,789

$156K

191
162 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

MUNAWAR AZAM MD

Internal Medicine

4,509

$253K

229
189 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

MIHAELA IOVANEL MD

Internal Medicine

11,033

$618K

537
440 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

AVANISH MEHTA M.D.

Internal Medicine

27,797

$1.56M

452
387 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

DANIEL VALICENTI MD

Internal Medicine

7,480

$419K

195
159 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

LEWIS WEINER MD

Internal Medicine

3,154

$176K

121
112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

VINCENT MARCACCIO M.D.

Internal Medicine

2,297

$128K

373
263 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

ELIZABETH TOLL MD

Internal Medicine

1,676

$93.1K

110
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

TIMOTHY AMASS M.D.

Internal Medicine

528

$29.3K

50
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

GLORIA SUN M.D.

Internal Medicine

3,991

$221K

256
221 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

GREGORY ALLEN D.O.

Internal Medicine

18,922

$1.05M

484
330 are 65+

14%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

IRFAN AHMAD M.D.

Internal Medicine

4,691

$258K

228
201 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

JOHN MCCAFFREY DO

Internal Medicine

5,577

$307K

207
195 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

LAURA OFSTEAD MD

Internal Medicine

6,127

$337K

289
246 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

LEONARD MANNARELLI D.O.

Internal Medicine

14,299

$784K

407
240 are 65+

16%
patients receiving schedule two controlled substances

Avg: 4%

20%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

ANTHONY LOMBARDI MD

Internal Medicine

27,497

$1.5M

768
637 are 65+

17%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

NITIN DAMLE MD

Internal Medicine

5,351

$292K

437
385 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank